dichlororibofuranosylbenzimidazole has been researched along with Herpes Simplex in 1 studies
Dichlororibofuranosylbenzimidazole: An RNA polymerase II transcriptional inhibitor. This compound terminates transcription prematurely by selective inhibition of RNA synthesis. It is used in research to study underlying mechanisms of cellular regulation.
Herpes Simplex: A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tigges, MA | 1 |
| Koelle, D | 1 |
| Hartog, K | 1 |
| Sekulovich, RE | 1 |
| Corey, L | 1 |
| Burke, RL | 1 |
1 other study available for dichlororibofuranosylbenzimidazole and Herpes Simplex
| Article | Year |
|---|---|
Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Topics: Acyclovir; Antigens, Viral; CD8 Antigens; Clone Cells; Cycloheximide; Cytotoxicity, Immunologic; Dac | 1992 |